Phase 1 Sepsis Clinical Trials
6 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–6 of 6 trials
Recruiting
Phase 1
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
Sepsis
Bayer36 enrolled20 locationsNCT06854640
Recruiting
Phase 1
A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.
Sepsis Associated Disseminated Intravascular Coagulation (DIC)
Bayer16 enrolled2 locationsNCT07176728
Recruiting
Phase 1
Intravenous DNase I for the Treatment of Sepsis (IDEALSepsisI)
SepsisCritical Illness
McMaster University36 enrolled1 locationNCT05453695
Recruiting
Phase 1
Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention
Sepsis
Children's Hospital of Philadelphia20 enrolled1 locationNCT07084129
Recruiting
Phase 1Phase 2
Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis
Sepsis
CHA University102 enrolled2 locationsNCT05136560
Terminated
Phase 1
Safe and effective use of aspirin in intensive care patients.
Sepsis
Royal Melbourne Hospital135 enrolled1 locationACTRN12611000649910